Thursday, September 29, 2022
News
NEWS HOME
PRN INDIA
BAL Pharma Limited announces Q1FY23 results
  SocialTwist Tell-a-Friend  
   

  • Formulation Business witnesses robust growth of 50% YoY
  • Export Formulation grows by 69.43% YoY to 307.71 million in Q1FY23

BENGALURU, India, Aug. 15, 2022 /PRNewswire/ -- BAL Pharma Limited, a fully integrated pharmaceuticals Company specialising in Bulk Drugs, Prescription Drugs, Generics, and pharma intermediates has announced its results for the Quarter ended 30th June 2022.

Financial Highlights (Standalone) – Q1FY23

Particulars (₹ Mn)

Q1FY23

Q1FY22

YoY

FY22

Revenue

700.71

711.38

-1.50 %

2,868.56

EBITDA

60.05

76.23

-21.23 %

296.92

PBT

18.06

29.59

-38.97 %

120.56

PAT

14.07

21.48

-34.50 %

85.73

EPS

0.95

1.45

-34.48 %

5.67

Financial Highlights

  • Revenue – The Company reported revenue of ₹ 700.71 million for Q1FY23 as compared to ₹ 711.38 million for Q1FY22. Revenue was impacted by macro and uncontrolled factors led by geopolitical concerns, external market turmoil and certain other unavoidable market factors. Such scenarios led to tighter inventory management and unavoidable price disruption which the company resisted to certain extent by focussing on other markets and also focussed on other formulations as well
  • EBITDA – EBITDA for Q1FY23 stood at ₹ 60.05 million as compared to ₹ 76.23 million for Q1FY22. Margins were impacted by lower Price realisations from API products, along with severe raw material prices increase. Global commodity inflation led to increase in various intermediate prices which impacted raw material costs. The Company has been attempting to lower the impact by adapting various raw material procurement strategies. The company has been strategizing alternate sources for its raw material procurement. This shall not only stabilize the cost but also create a long-term sustainable approach in its overall strategy
  • PAT: PAT for Q1FY23 stood at ₹14.07 million as compared to ₹21.48 million for Q1FY22.
  • Formulation Business: The formulation business remained the revenue growth driver and witnessed robust growth of 50% whereas export formulation grew by 69.43% and stood at ₹307.71 million for Q1FY23 as compared to ₹181.62 million for Q1FY22. Domestic formulation grew by 2.96% and stood at ₹77.66 million for Q1FY23 as compared to ₹75.43 million for Q1FY22.
  • API Business: API business revenue stood at ₹303.49 million for Q1FY23 as compared to ₹446.1 million for Q1FY22.

Formulations Business(FDF) - the revenue growth driver

  • Formulations segment revenue stood at ₹385.37 million in Q1FY23 as compared to ₹257.05 million in Q1FY22.
  • Exports to Domestic was at 71:29 in Q1FY23 versus 80:20 in Q1FY23.
  • The share of formulations in total revenue increased to 56% in Q1FY23 from 37% in Q1FY22. Formulation exports witnessed a robust growth of 69.43% YoY for Q1FY23.
  • The company has setup A phytoceutical division for its herbal line products which caters to the niche category of consumers who prefer natural and herbal products for their lifestyle
  • The order book for formulation stands at ₹270 million as on Q1FY23.

API Business – an integrated business model

  • API segment revenue stood at ₹303.49 million in Q1FY23 as compared to ₹446.1 million in Q1FY22.
  • The share of API in total revenue is 44% in Q1FY23 as compared to 63% in Q1FY22.
  • Exports: Domestic mix was 70:30 in Q1FY22 versus 58:42 in Q1FY23.
  • The total Order book for APIs remains strong at ₹370 million as on Q1FY23. APIs such as Alfuzosin for prostate enlargement, and Dabigatran for cardiac care are under scale-up. Along with these APIs, Total of 8 products are under development and scale-up.

Operational Highlights

Expanding into new Geographies- BAL Pharma is expanding its footprints into new geographies in both segments. In API, they have expanded their presence in Uzbekistan, Guatemala, and Malta. This geographical expansion will add more value to the business and ultimately enhance profitability in the coming years.

New Customers- Backed by a strong medical representative and marketing team, BAL Pharma is constantly adding new customers from various geography and enhancing the customer base. They have added nine customers in the API segment and two customers in the exports formulations segment. They are constantly strengthening their customer base which is an indication of their efforts and commitment to the business. The customer base assures the business sustainability & profitability and provides a positive long-term outlook about the business.

Enriched product pipeline- The Company has a strong product pipeline and robust order book in both API and Product segments. Backed by a strong pipeline, the company's overall business outlook looks positive and promising. Company product pipeline in API is ₹370 million and Formulations is ₹270 million.

Future Readiness- There is tremendous growth opportunity in the pharmaceuticals industry. The Government is extending enormous support to pharmaceutical companies by launching the PLI scheme. Bal Pharma is a beneficiary of this PLI scheme. The Company expects an average annual turnover of INR 1,250 million p.a from the eligible products in the next 5 to 6 years. BAL Pharma is strengthening and preparing themselves under all the parameters to cater to the maximum market opportunity and market share. They have more than two decades of experience, five manufacturing facilities, 200+ finished products, 80+ presence across the countries, 370 tonnes API capacity, 22+ API molecules and 1000+ employee strength. Additionally, they have hired seasoned professionals, are strengthening the marketing team, and deploying the required CAPEX in offices and units. All these long and short-term initiatives will collectively contribute and enable them to cater to the maximum available market opportunity.

Commenting on financial results, Mr. Shailesh Siroya, Managing Director, BAL Pharma said, "Despite several challenges in the marketplace - both on the demand and the supply side, we turned out a resilient set of numbers for Q1FY23. We had to navigate through a volatile market, inflated raw material procurement costs, and steep fuel and freight charges. We also made investments in hiring highly qualified professionals to support our ambitions. I expect them to take our operational excellence to a different level and bolster our journey towards quality growth. On the positive side, the Company has a robust product pipeline, and is strategically improving its presence in both domestic and international markets. In particular, our formulations business is gaining solid momentum by growing 50% YoY – which should help improve our margins profile continually. Recently, we have expanded into three new geographies and added strategic new customers that will bode well for us in the long term. Government support in the form of PLI scheme will further boost our overall growth strategy. Going forward, we foresee strong demand growth for our various products, and we are placing concerted efforts for improving our profitability in the coming quarters."

About BAL Pharma Ltd (BPL)

Bal Pharma Limited (BSE: 524824) (NSE: BALPHARMA) is a fully integrated pharmaceuticals Company specialising in Bulk Actives, Prescription Drugs, Generics and pharma intermediates. Bal Pharma's focused therapeutic areas are Anti-diabetes, Anti-histamine, Anti-inflammatory, Acne Treatment, Gastroenterology, Cardiology, and dermatology. The Company is one of the largest producers and exporters of Gliclazide, a medicine to treat type-2 diabetes. Bal Pharma's niche APIs and FDFs are produced at world-class manufacturing facilities located in Karnataka, Maharashtra, Rajasthan and Uttarakhand. The Company exports APIs to Europe, Australia, Japan, the Far East, Canada, Latin America, Africa, the Middle East and other World markets. Its FDFs are exported to a Semi-regulated market, besides having a domestic presence. Backed by strength in Research and Development, and strong infrastructure, Bal Pharma is poised to become a significant Company in the pharmaceutical industry.

Forward-Looking Statement:

Certain statements in this document may be forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties like regulatory changes, local political or economic developments, technological risks, and many other factors that could cause our actual results to differ materially from those contemplated by the relevant forward-looking statements. BAL Pharma Limited will not be in any way responsible for any action taken based on such statements and undertakes no obligation to publicly update these forward-looking statements to reflect subsequent events or circumstances

More News by PR Newswire India

LyondellBasell Postpones Restart of Berre, France Cracker until Next Year

SI GROUP EXPANDS LUBRICANT ADDITIVE PORTFOLIO WITH NEW AMINIC ANTIOXIDANT

KEREN AVIDAR NAMED INX GLOBAL GENERAL COUNSEL

Asian Hall of Fame Announces Induction 2022

ViewSonic Expands its Gaming Monitor Line with the New OMNI Series for Casual Gamers

Fibocom Launches New Generation of 5G Sub-6GHz and mmWave Module FX170(W) Series Based on Snapdragon X65 5G Modem-RF System at MWC Las Vegas 2022

Himalaya Wellness Company Partners with NIMHANS to Launch Project SURAKSHA

Dr. Giovanni De Micheli Honored with 2022 Phil Kaufman Award Presented by ESD Alliance and IEEE CEDA

Dynata's Global Consumer Trends survey: 53% of people are struggling to afford basic needs; 67% have reduced spending to combat inflation

BellSoft Releases Alpaquita Cloud Native Platform for Java Developers

LCOE-centered, 600W+ module drives global PV market with four key competencies

ABILITY DIABETES GLOBAL - A Landmark RCT in the field of PCI for patients with DM, completes Enrolment

Bitget Ranks As The Top Crypto Derivatives Exchange With 0 Trading Fees

CRMNEXT features in Gartner® Magic Quadrant 2022 as 'Visionary' in Sales Force Automation technology

IBIS STYLES ENTERS THE METAVERSE WITH 2022 'OPEN TO CREATORS' VIRTUAL ART GALLERY & CONTEST - FEATURING DIGITAL CREATORS FROM AROUND THE WORLD

Former CEO of Tricentis and renowned testing industry veteran, Sandeep Johri joins LambdaTest's board

Trina Solar Demonstrates Commitment to India, Showcases Cutting Edge N-Type Module at REI Expo 2022

Lifestyle's new festive campaign inspires one to groove in style

ZTE endorses Catalyzing Electrification Accord

FPT Industrial announces the acquisition of a minority stake in Blue Energy Motors

Moonfare Expands Foothold to India opening Digital Private Market Investing Platform to eligible investors

Ideanomics' subsidiary Energica to provide electric motorcycles for the upcoming G20 Bali summit

DBS Bank India collaborates with HDFC ERGO and Atradius to provide Trade Credit Insurance solution to Tata Metaliks

AFFINIS helps organizations ease compliance with the Structured Digital Database requirements of SEBI

Daiichi Sankyo joins Startup Creasphere's Program Powered by Plug and Play

Handheld releases new Nautiz X81: An ultra-rugged 5G Android 12 handheld with a familiar feel

The Mindful Foundation brings courses from Oxford Mindfulness Foundation to India

UST Recognized for Human Resources Excellence Across Nine Categories at the 2022 Brandon Hall Awards

ScentAir Continues its Sustainability Initiatives to Enhance Immersive Sensory Experience

Sweden spellbinds travellers with new chilling audio story

Edvoy launches 'Refer a friend' programme as thank you to student advocates

Pharming Announces US FDA Acceptance for Priority Review of its New Drug Application for Leniolisib

WinWire Has Earned the Modernization of Web Applications to Microsoft Azure Advanced Specialization

UNIVERSAL MUSIC INDIA ACQUIRES MAJORITY STAKE IN TM VENTURES, A LEADING INDIAN MUSIC & ENTERTAINMENT COMPANY

M&M'S® Welcomes First New Character in a Decade

Global Business Leaders Say Hybrid Cloud is Critical to Modernization, Yet Security, Skills and Compliance Concerns Impede Success

GLOBAL STANDARD OF CARE SIGNIFICANTLY REDUCED DUE TO MENTAL HEALTH OF HEALTHCARE WORKERS

Vieworks to Showcase Industrial Cameras and Lenses at VISION 2022

Eviation's Alice Achieves Milestone with First Flight of All-Electric Aircraft

SAUDI ARABIA IS THE FASTEST GROWING TOURISM DESTINATION IN THE G20

Internet sensation Khaby Lame announced as QNB Group's Official FIFA World Cup Qatar 2022™ Brand Ambassador

GIGABYTE Launches Z790 Series Motherboards Supporting Dual-Generation Intel Processors

Deltek Research to Unveil Top Federal Contracting Opportunities for 2023

ViewSonic Unveils Industry-First Foldable 135" All-in-One LED Display Solution Kit

NEOM Tech & Digital Company steps into the future as 'Tonomus'

Global Fab Equipment Spending Forecast to Reach All-Time High of Nearly $100 Billion in 2022, SEMI Reports

Kohler India celebrates their 10th Year of Pecha Kucha in New Delhi, India

U.S. Soy Sustainability Assurance Protocol (SSAP) Certificates Can Now Be Transferred

CP KELCO PARTNERS WITH EXOPOLYMER TO BRING NEXT-GENERATION FUNCTIONAL BIOPOLYMERS TO MARKET

Old Mission Selects Solace to Support Rapid Growth of Business through Event-Driven Architecture

GIGABYTE Launches Four AMD X670 Motherboards for New Ryzen 7000 Processors

SRK Knowledge Foundation announces transformational partnership with The Global Network for Zero

LyondellBasell Announces Organizational Changes

HarperCollins India presents HAPPILY INSURED: Your Guide to Understanding Insurance and Leading a Stress-Free Life by Kapil Mehta

Hisense Unveils Its FIFA World Cup Qatar 2022™ TVC "Perfect Match" Ahead of Tournament

The 2022 4th "My China Story" International Short Video Competition Award Ceremony was held in Hangzhou, Zhejiang

Light up the festive season with 'Sale Dhamaka' on MSI's laptop range

GLOBAL LEADERS, EXPERTS, AND CULTURAL ICONS CONVENE AT THE MILKEN INSTITUTE ASIA SUMMIT TO CELEBRATE A TRANSFORMED WORLD

Bank of Baroda rolls out 'Khushiyon ka Tyohaar' as the Festive Season begins

XCMG New Port Machinery's High-end Intelligent Industrial Development Project Base Launches Production

NATIONAL INSTITUTE FOR HEALTH AND CARE RESEARCH CONDUCTS A GLOBAL ANNUAL MEETING TO ADDRESS RESEARCH IN SURGERY IN INDIA

DEAKIN UNIVERSITY HUBS to be set up in India at OP Jindal Global University, Symbiosis International University and Chitkara University

TargEDys and Inoliva announce they have entered a distribution partnership to bring Satylia® to Turkey

Top 50 Start-ups Bringing Innovation to the Global Homes and Buildings Industry

How Healthcare Organizations Can Enhance a Holistic Patient and Member View by Improving Insights from Data

Tata AIA Life Fortune Guarantee Pension gets a powerful upgrade

PDRL aims to certify 10,000+ candidates on AeroMegh Platform in the Drone Industry by the year 2024

DAZN ACCELERATES GLOBAL GROWTH MOMENTUM WITH ACQUISITION OF ELEVEN GROUP BUSINESSES

GoingZero Big Diwali Sale: Up to 40% Discount And Free Shipping On Zero Waste Products

Slow-fashion brand FREECULTR becomes the official merchandise partner for FIFA 2022™

Purple Quarter Facilitates HCAH's CTO, Ex-DealShare Techie Onboarded

Ghodawat Consumer awarded - Fastest growing FMCG Company of 2022

Cine Star Cricket League launched with television and entertainment industry's Divas

ELLE FANNING IS THE AMBASSADOR OF FAME, PACO RABANNE'S NEW FEMININE FRAGRANCE

Saudi Data, AI Authority (SDAIA) and Ministry of Energy Partner with IBM to Accelerate Sustainability Initiatives in Saudi Arabia Using AI

Unstoppable Women of Web3 Launches New Education Streams

PNAS Partners with Straive for Production Services

MOBILEUM convenes the region's leading telecom operators at WEMEET ASIA 2022

Bizverse has officially become a Meta long-term strategic partnership

STL divests IDS as a part of its ongoing portfolio realignment

Frost & Sullivan Honors Tampa Electric Company and Warren, Simpson & Butler County Water Districts with Itron Excellence in Resourcefulness Awards

Mindray Showcases Hematology Innovations and Academic Achievements to the World at ISLH 2022

Deepak Chopra & Seva.Love Announce "ChopraVerse: House of Enlightenment," the Metaverse for Wellbeing in Collaboration with Utopia

MSC TO DEVELOP AIR CARGO SOLUTION IN RESPONSE TO MARKET DEMAND

Harpercollins is proud to announce the upcoming release of The Anarchist Cookbook: A Toolkit to Protest and Peaceful Resistance by Aakar Patel Illustrations by PenPencilDraw

Saudi Arabia launches Nusuk, an integrated digital platform, to facilitate pilgrim journeys for visitors from around the world

MEIL's wholly owned subsidiary MeghaGas, now MCGDPL, to execute City Gas Distribution

Yabx emerges as a leader in digital lending platforms at the top Global Fintech Awards

FII Institute reveals the world's top priority is the rising cost of living

All about IBSAT - One of the Top MBA Entrance Exams in India

MAPIC India 2022 honors India's most admired retail and tech innovators at the MAPIC India Retail Awards

Hasiru Dala Innovations joins forces with Satma CE to give immutable waste traceability from collection to final product made from waste

Bank of Baroda launches Baroda Tiranga Deposits

Alicon Castalloy Limited wins large, multi-year order from Jaguar Land Rover for eMobility Platform

mCaffeine's Biggest Body Care Launch Gets an Overwhelming Response from the Audience: 1 Consumer Subscribed Every 3 Seconds for the Launch

On World Lung Day, Alkem Laboratories pledge to spread awareness about lung diseases through its initiative 'The Healthy Lungs'

LONGi is to showcase its award-winning Hi-MO 5 Series at the Renewable Energy India Expo 2022, unveiling its new Hydrogen Business exclusively for Indian customers

LEXUS INDIA ANNOUNCES MENTORS FOR THE LEXUS DESIGN AWARD INDIA 2023

Mane Kancor CEO Geemon Korah hailed as one of the best CEO's in India

SVKM's NMIMS signs an MoU with HTWG Konstanz, Germany, for short study and research

Top HR Chiefs from TTK Prestige, Silicon Labs, Virtusa, Bureau Veritas at Woxsen's Global HR Leadership Conclave 2022

Mastercard expands decades-long football legacy through GUINNESS WORLD RECORDS™ title with Luis Figo

Soroco and Whatfix Announce Strategic Partnership

ElevenEs produces a prototype of the largest LFP battery cell in Europe

SHEIN CELEBRATED "ROCK THE RUNWAY: SHEIN FOR ALL", ITS FW22 FASHION SHOW

Huawei Hosts the 9th Global Rail Summit in Berlin

Campus With A Conscience hosts a-week long SDG festival

Woxsen University spearheading the internationalisation of higher education in the region through brand new initiatives

 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
INDIA WORLD ASIA
4.5-magnitude earthquake hits Andaman an...
Sacrosanct duty of husband to maintain w...
Prohibition raid leaves Bihar police sta...
Mumbai: Lata Mangeshkar music college la...
Defence Minister visits frontline areas ...
'Undemocratic': Jamaat-e-Islami opposes ...
More...    
 
 Top Stories
EAM Jaishankar assures US administr... 
Arrest warrant issued against produ... 
Delhi HC dismisses plea of Facebook... 
Afghan women face social, economic ... 
Delhi Police arrests shooters of Go... 
India strives for relationship buil... 
Mamata Banerjee plays 'dhak' at Dur... 
Pak: Rana Sanaullah-led high level ...